Sinotherapeutics Inc. (SHA:688247)
China flag China · Delayed Price · Currency is CNY
10.25
-0.12 (-1.16%)
Mar 13, 2025, 4:00 PM CST

Sinotherapeutics Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Market Capitalization
4,7464,5174,9787,593--
Upgrade
Market Cap Growth
-9.26%-9.26%-34.45%---
Upgrade
Enterprise Value
3,9983,7694,1946,771--
Upgrade
Last Close Price
10.5710.0610.9016.54--
Upgrade
PE Ratio
37.7535.2281.5081.71--
Upgrade
PS Ratio
9.448.8116.6030.67--
Upgrade
PB Ratio
3.843.654.116.45--
Upgrade
P/TBV Ratio
3.783.784.286.74--
Upgrade
P/OCF Ratio
--384.14103.76--
Upgrade
EV/Sales Ratio
7.807.3513.9927.35--
Upgrade
EV/EBITDA Ratio
24.8623.4368.7780.84--
Upgrade
EV/EBIT Ratio
27.7326.1494.67116.32--
Upgrade
Debt / Equity Ratio
0.000.000.000.000.01-
Upgrade
Debt / EBITDA Ratio
0.000.000.000.020.04-
Upgrade
Debt / FCF Ratio
----0.03-
Upgrade
Asset Turnover
--0.220.230.390.51
Upgrade
Inventory Turnover
--2.341.961.712.29
Upgrade
Quick Ratio
--9.139.766.213.37
Upgrade
Current Ratio
--10.4910.596.913.83
Upgrade
Return on Equity (ROE)
10.48%10.48%5.12%9.87%21.29%24.97%
Upgrade
Return on Assets (ROA)
--2.06%3.31%7.41%12.26%
Upgrade
Return on Capital (ROIC)
7.36%7.36%2.32%3.85%9.35%15.53%
Upgrade
Return on Capital Employed (ROCE)
--3.49%4.69%12.25%20.57%
Upgrade
Earnings Yield
2.70%2.84%1.23%1.22%--
Upgrade
FCF Yield
--0.52%-1.36%--
Upgrade
Dividend Yield
0.47%-0.38%0.37%--
Upgrade
Payout Ratio
0.00%-46.02%---
Upgrade
Buyback Yield / Dilution
2.52%2.52%-11.22%-3.32%-0.21%-
Upgrade
Total Shareholder Return
2.99%2.52%-10.84%-2.95%-0.21%-
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.